Wide Ranks

AXGN

AxoGen, Inc.

14.07

Top Statistics
Market Cap 619 M Forward PE 45.98 Revenue Growth 17.90 %
Current Ratio 3.75 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -7.91 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -360.38 Enterprise / Revenue 3.68 Price To Sales Trailing12 Months 3.42
Profitability
Profit Margins -7.91 % Operating Margins -0.65 %
Balance Sheet
Total Cash 24 M Total Cash Per Share 0.5570 Total Debt 71 M
Total Debt To Equity 71.73 Current Ratio 3.75 Book Value Per Share 2.26
All Measures
Short Ratio 242.00 % Message Board Id finmb_20946777 Fax 386 462 6801
Shares Short Prior Month 1 M Return On Equity -0.1451 City Alachua
Uuid 7bcdc4f6-2582-3323-ab9e-9d3722f90de9 Previous Close 13.61 First Trade Date Epoch Utc 535 M
Book Value 2.26 Beta 1.13 Total Debt 71 M
Volume 188554 Price To Book 6.23 Last Split Date 773 M
Fifty Two Week Low 5.55 Total Cash Per Share 0.5570 Total Revenue 180 M
Shares Short Previous Month Date 1 B Target Median Price 17.50 Max Age 86400
Recommendation Mean 1.33 Sand P52 Week Change 0.3133 Operating Margins -0.65 %
Last Dividend Value 1.00 Target Mean Price 17.83 Net Income To Common -14307000
Short Percent Of Float 0.0283 Implied Shares Outstanding 44 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 282770 Average Volume10days 282770
Total Cash 24 M Next Fiscal Year End 1 B Revenue Per Share 4.16
Held Percent Insiders 0.0555 Ebitda Margins -1.02 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 13.61
Target Low Price 17.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 13.70
Open 13.74 Free Cashflow -4372250 State FL
Dividend Yield 0.00 % Return On Assets -0.0275 Time Zone Short Name EST
Trailing Eps -0.3300 Day Low 13.65 Address1 13631 Progress Boulevard
Shares Outstanding 44 M Price Hint 2 Target High Price 20.00
Website https://www.axogeninc.com 52 Week Change 1.15 Average Volume 396190
Forward Eps 0.3100 Recommendation Key strong_buy Compensation As Of Epoch Date 1 B
Quick Ratio 213.40 % Last Split Factor 105:100 Regular Market Day High 14.11
Is_sp_500 False Profit Margins -7.91 % Debt To Equity 71.73
Fifty Two Week High 15.90 Day High 14.11 Shares Short 1 M
Regular Market Open 13.74 Industry Key medical-devices Earnings Growth 0.00 %
Enterprise To Revenue 3.68 Revenue Growth 17.90 % Shares Percent Shares Out 0.0238
Operating Cashflow -4411000 Currency USD Time Zone Full Name America/New_York
Market Cap 619 M Is_nasdaq_100 False Zip 32615
Quote Type EQUITY Industry Medical Devices Ex Dividend Date 1 B
Regular Market Day Low 13.65 Held Percent Institutions 0.8460 Long Name Axogen, Inc.
Current Price 14.07 Address2 Suite 400 Enterprise To Ebitda -360.38
Financial Currency USD Current Ratio 3.75 Gross Margins 78.75 %
Industry Disp Medical Devices Number Of Analyst Opinions 6 Country United States
Float Shares 38 M Two Hundred Day Average 9.96 Enterprise Value 665 M
Price To Sales Trailing12 Months 3.42 Forward PE 45.98 Regular Market Volume 188554
Last Dividend Date 1 B Ebitda -1848000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.

The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries.

Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin.

The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons.

Axogen, Inc. is headquartered in Alachua, Florida.